NM_014244.5:c.220G>A

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_014244.5(ADAMTS2):​c.220G>A​(p.Val74Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00111 in 1,610,868 control chromosomes in the GnomAD database, including 30 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Synonymous variant affecting the same amino acid position (i.e. V74V) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.00082 ( 5 hom., cov: 34)
Exomes 𝑓: 0.0011 ( 25 hom. )

Consequence

ADAMTS2
NM_014244.5 missense

Scores

6
11

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: 0.738

Publications

7 publications found
Variant links:
Genes affected
ADAMTS2 (HGNC:218): (ADAM metallopeptidase with thrombospondin type 1 motif 2) This gene encodes a member of the ADAMTS (a disintegrin and metalloproteinase with thrombospondin motifs) protein family. Members of the family share several distinct protein modules, including a propeptide region, a metalloproteinase domain, a disintegrin-like domain, and a thrombospondin type 1 (TS) motif. Individual members of this family differ in the number of C-terminal TS motifs, and some have unique C-terminal domains. The encoded preproprotein is proteolytically processed to generate the mature procollagen N-proteinase. This proteinase excises the N-propeptide of the fibrillar procollagens types I-III and type V. Mutations in this gene cause Ehlers-Danlos syndrome type VIIC, a recessively inherited connective-tissue disorder. Alternative splicing results in multiple transcript variants, at least one of which encodes an isoform that is proteolytically processed. [provided by RefSeq, Feb 2016]
ADAMTS2 Gene-Disease associations (from GenCC):
  • Ehlers-Danlos syndrome, dermatosparaxis type
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp, Orphanet, G2P, PanelApp Australia, Illumina

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.009521455).
BP6
Variant 5-179344081-C-T is Benign according to our data. Variant chr5-179344081-C-T is described in CliVar as Benign. Clinvar id is 353145.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr5-179344081-C-T is described in CliVar as Benign. Clinvar id is 353145.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr5-179344081-C-T is described in CliVar as Benign. Clinvar id is 353145.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr5-179344081-C-T is described in CliVar as Benign. Clinvar id is 353145.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr5-179344081-C-T is described in CliVar as Benign. Clinvar id is 353145.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr5-179344081-C-T is described in CliVar as Benign. Clinvar id is 353145.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population eas. GnomAd4 allele frequency = 0.00082 (125/152348) while in subpopulation EAS AF = 0.0172 (89/5182). AF 95% confidence interval is 0.0143. There are 5 homozygotes in GnomAd4. There are 74 alleles in the male GnomAd4 subpopulation. Median coverage is 34. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 5 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ADAMTS2NM_014244.5 linkc.220G>A p.Val74Met missense_variant Exon 2 of 22 ENST00000251582.12 NP_055059.2 O95450-1
ADAMTS2NM_021599.4 linkc.220G>A p.Val74Met missense_variant Exon 2 of 11 NP_067610.1 O95450-2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ADAMTS2ENST00000251582.12 linkc.220G>A p.Val74Met missense_variant Exon 2 of 22 1 NM_014244.5 ENSP00000251582.7 O95450-1
ADAMTS2ENST00000274609.5 linkc.220G>A p.Val74Met missense_variant Exon 2 of 11 1 ENSP00000274609.5 O95450-2
ADAMTS2ENST00000518335.3 linkc.220G>A p.Val74Met missense_variant Exon 2 of 21 3 ENSP00000489888.2 A0A1B0GTY3
ADAMTS2ENST00000698889.1 linkn.220G>A non_coding_transcript_exon_variant Exon 2 of 21 ENSP00000514008.1 A0A8V8TMU7

Frequencies

GnomAD3 genomes
AF:
0.000821
AC:
125
AN:
152230
Hom.:
5
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.0171
Gnomad SAS
AF:
0.000621
Gnomad FIN
AF:
0.00245
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000103
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.00173
AC:
413
AN:
238496
AF XY:
0.00144
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.0000585
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.0174
Gnomad FIN exome
AF:
0.00365
Gnomad NFE exome
AF:
0.000124
Gnomad OTH exome
AF:
0.00119
GnomAD4 exome
AF:
0.00114
AC:
1669
AN:
1458520
Hom.:
25
Cov.:
35
AF XY:
0.00110
AC XY:
800
AN XY:
725258
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
33422
American (AMR)
AF:
0.0000448
AC:
2
AN:
44632
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26030
East Asian (EAS)
AF:
0.0344
AC:
1364
AN:
39622
South Asian (SAS)
AF:
0.000197
AC:
17
AN:
86116
European-Finnish (FIN)
AF:
0.00385
AC:
200
AN:
51924
Middle Eastern (MID)
AF:
0.000347
AC:
2
AN:
5756
European-Non Finnish (NFE)
AF:
0.0000369
AC:
41
AN:
1110764
Other (OTH)
AF:
0.000714
AC:
43
AN:
60254
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.477
Heterozygous variant carriers
0
101
203
304
406
507
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000820
AC:
125
AN:
152348
Hom.:
5
Cov.:
34
AF XY:
0.000993
AC XY:
74
AN XY:
74498
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
41586
American (AMR)
AF:
0.00
AC:
0
AN:
15308
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.0172
AC:
89
AN:
5182
South Asian (SAS)
AF:
0.000621
AC:
3
AN:
4830
European-Finnish (FIN)
AF:
0.00245
AC:
26
AN:
10624
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.000103
AC:
7
AN:
68024
Other (OTH)
AF:
0.00
AC:
0
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.466
Heterozygous variant carriers
0
5
10
14
19
24
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00109
Hom.:
11
Bravo
AF:
0.000593
ExAC
AF:
0.00171
AC:
206
Asia WGS
AF:
0.00722
AC:
25
AN:
3478
EpiCase
AF:
0.000218
EpiControl
AF:
0.00

ClinVar

Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Ehlers-Danlos syndrome, dermatosparaxis type Benign:3
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Nov 11, 2019
Natera, Inc.
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Dec 19, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Ehlers-Danlos syndrome Benign:1
Apr 14, 2021
Genome Diagnostics Laboratory, The Hospital for Sick Children
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
Jul 29, 2019
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.16
BayesDel_addAF
Benign
-0.48
T
BayesDel_noAF
Benign
-0.42
CADD
Pathogenic
27
DANN
Uncertain
1.0
DEOGEN2
Benign
0.13
T;.;.
Eigen
Uncertain
0.38
Eigen_PC
Uncertain
0.39
FATHMM_MKL
Uncertain
0.79
D
MetaRNN
Benign
0.0095
T;T;T
MetaSVM
Benign
-0.95
T
MutationAssessor
Benign
1.7
L;.;L
PhyloP100
0.74
PrimateAI
Uncertain
0.75
T
PROVEAN
Benign
-0.75
N;.;N
REVEL
Benign
0.11
Sift
Benign
0.044
D;.;T
Sift4G
Uncertain
0.026
D;.;D
Polyphen
0.99
D;.;D
Vest4
0.17
MVP
0.38
MPC
0.98
ClinPred
0.056
T
GERP RS
4.2
Varity_R
0.15
gMVP
0.52
Mutation Taster
=97/3
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2271211; hg19: chr5-178771082; API